Clinical Trial Update: Sipuleucel-T With or Without Radiation Therapy in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial assessing sipuleucel-T with or without radiation therapy in hormone-resistant metastatic prostate cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hormone-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• sipuleucel-T (sipuleucel-T)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Adenocarcinoma of the Prostate, Bone Metastases | Phase 2 | Status: COMPLETED | Results posted: 2020-08-25